Total Payments
$26,559
2024 Payments
$6,193
Companies
44
Transactions
718
Medicare Patients
3,208
Medicare Billing
$424,197
Payment Breakdown by Category
Other$13,313 (50.1%)
Food & Beverage$13,209 (49.7%)
Education$37.48 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,209 | 709 | 49.7% |
| Long term medical supply or device loan | $12,000 | 2 | 45.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,313 | 2 | 4.9% |
| Education | $37.48 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cambridge Interventional LLC | $13,356 | 5 | $0 (2024) |
| Lilly USA, LLC | $1,715 | 95 | $0 (2023) |
| Novo Nordisk Inc | $1,562 | 86 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $1,309 | 65 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,185 | 70 | $0 (2021) |
| ABBVIE INC. | $794.79 | 48 | $0 (2024) |
| Shire North American Group Inc | $740.29 | 22 | $0 (2019) |
| Amgen Inc. | $450.58 | 23 | $0 (2020) |
| IBSA Pharma Inc. | $425.29 | 27 | $0 (2023) |
| Currax Pharmaceuticals LLC | $387.61 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,193 | 10 | Cambridge Interventional LLC ($6,000) |
| 2023 | $7,836 | 25 | Cambridge Interventional LLC ($7,356) |
| 2022 | $646.00 | 33 | Horizon Therapeutics plc ($169.55) |
| 2021 | $932.47 | 51 | Lilly USA, LLC ($237.39) |
| 2020 | $2,143 | 116 | SANOFI-AVENTIS U.S. LLC ($406.04) |
| 2019 | $3,153 | 174 | SANOFI-AVENTIS U.S. LLC ($500.84) |
| 2018 | $2,897 | 155 | Novo Nordisk Inc ($352.91) |
| 2017 | $2,759 | 154 | Lilly USA, LLC ($485.75) |
All Payment Transactions
718 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Cambridge Interventional LLC | CRF (Device) | Long term medical supply or device loan | In-kind items and services | $6,000.00 | General |
| Category: RFA | ||||||
| 11/20/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/14/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: ENDOCRINE AGENT | ||||||
| 06/17/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $51.46 | General |
| Category: ENDOCRINE AGENT | ||||||
| 03/26/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/31/2023 | Cambridge Interventional LLC | CRF (Device) | Long term medical supply or device loan | In-kind items and services | $6,000.00 | General |
| Category: RFA | ||||||
| 12/20/2023 | Cambridge Interventional LLC | CRF (Device) | Food and Beverage | Cash or cash equivalent | $43.64 | General |
| Category: RFA | ||||||
| 12/13/2023 | Cambridge Interventional LLC | CRF (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $437.50 | General |
| Category: RFA | ||||||
| 11/28/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2023 | Cambridge Interventional LLC | CRF (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $875.00 | General |
| Category: RFA | ||||||
| 11/11/2023 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: ENDOCRINE AGENT | ||||||
| 10/30/2023 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $25.20 | General |
| 09/29/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $87.32 | General |
| Category: Oncology | ||||||
| 09/28/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $39.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2023 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: ENDOCRINE AGENT | ||||||
| 08/31/2023 | Lilly USA, LLC | RETEVMO (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Oncology | ||||||
| 08/16/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 871 | 1,147 | $470,742 | $114,049 |
| 2022 | 6 | 851 | 1,117 | $472,379 | $115,168 |
| 2021 | 6 | 758 | 1,018 | $430,805 | $106,801 |
| 2020 | 5 | 728 | 1,014 | $380,471 | $88,179 |
Total Patients
3,208
Total Services
4,296
Medicare Billing
$424,197
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 385 | 610 | $249,198 | $59,611 | 23.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 280 | 312 | $109,957 | $27,103 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $39,304 | $9,042 | 23.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 65 | 76 | $33,609 | $8,488 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 47 | $27,001 | $7,093 | 26.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 23 | 29 | $11,673 | $2,711 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 373 | 573 | $237,222 | $57,410 | 24.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 255 | 307 | $112,055 | $27,294 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $40,996 | $10,048 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 66 | $38,940 | $9,791 | 25.1% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 59 | 64 | $29,504 | $7,252 | 24.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 32 | 33 | $13,662 | $3,375 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 376 | 607 | $255,452 | $62,875 | 24.6% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 238 | 261 | $97,283 | $24,244 | 24.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 57 | 57 | $31,542 | $7,925 | 25.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 37 | $21,829 | $5,431 | 24.9% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 41 | 43 | $19,187 | $4,855 | 25.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 13 | $5,512 | $1,471 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 379 | 632 | $222,901 | $51,916 | 23.3% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 211 | 231 | $85,008 | $19,808 | 23.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 52 | 52 | $28,236 | $5,807 | 20.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 42 | 47 | $22,278 | $5,505 | 24.7% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2020 | 44 | 52 | $22,048 | $5,143 | 23.3% |
About Dr. Agustin Andrade, MD
Dr. Agustin Andrade, MD is a Specialist healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104869064.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Agustin Andrade, MD has received a total of $26,559 in payments from pharmaceutical and medical device companies, with $6,193 received in 2024. These payments were reported across 718 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($13,209).
As a Medicare-enrolled provider, Andrade has provided services to 3,208 Medicare beneficiaries, totaling 4,296 services with total Medicare billing of $424,197. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Miami Beach, FL
- Active Since 06/14/2006
- Last Updated 04/09/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1104869064
Products in Payments
- CRF (Device) $13,356
- FARXIGA (Drug) $1,168
- CONTRAVE (Drug) $734.87
- Saxenda (Drug) $652.80
- JARDIANCE (Drug) $647.66
- NATPARA (Drug) $559.50
- SYNTHROID (Drug) $480.44
- Ozempic (Drug) $462.68
- UNITHROID (Drug) $459.23
- BAQSIMI (Drug) $454.45
- HUMULIN (Drug) $442.46
- Tirosint (Drug) $405.29
- SOLIQUA 100/33 (Biological) $404.56
- JANUVIA (Drug) $316.68
- SOLIQUA 100/33 (Drug) $306.46
- Repatha (Biological) $304.35
- TOUJEO (Drug) $263.05
- Omnipod (Device) $246.76
- Victoza (Drug) $245.38
- PRALUENT (Biological) $222.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Miami Beach
Dr. Mike Cusnir, M.d, M.D
Specialist — Payments: $297,209
Specialist $297,209
Dr. Ettore Vulcano, M.d, M.D
Specialist — Payments: $236,418
Specialist $236,418
Dr. Martin Zaiac, M.d, M.D
Specialist — Payments: $47,479
Specialist $47,479
Juan Rivera, Md, MD
Specialist — Payments: $36,966
Specialist $36,966
Dr. Arnold Blaustein, M.d, M.D
Specialist — Payments: $34,776
Specialist $34,776
Dr. Michael Schwartz, M.d, M.D
Specialist — Payments: $33,081
Specialist $33,081